Azelastine is safe and well tolerated in both adults and children with [[allergic rhinitis]].<ref>{{cite journal|last1=McNeely|first1=W|last2=Wiseman|first2=LR|title=Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.|journal=Drugs|date=July 1998|volume=56|issue=1|pages=91–114|pmid=9664202|doi=10.2165/00003495-199856010-00011}}</ref><ref name="Ratner et al, 1994">{{cite journal |vauthors=Ratner PH, Findlay SR, Hampel F, van Bavel J, Widlitz MD, Freitag JJ |title=A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis |journal=The Journal of Allergy and Clinical Immunology |volume=94 |issue=5 |pages=818–25 |date=November 1994 |pmid=7963150 |doi=10.1016/0091-6749(94)90148-1}}</ref><ref name="LaForce et al, 1996">{{cite journal |vauthors=LaForce C, Dockhorn RJ, Prenner BM |title=Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial |journal=Annals of Allergy, Asthma & Immunology |volume=76 |issue=2 |pages=181–8 |date=February 1996 |pmid=8595539 |doi=10.1016/S1081-1206(10)63420-5|display-authors=etal}}</ref> Bitter taste, headache, nasal burning and [[somnolence]] are the most frequently reported adverse events. US prescribing recommendations warn against the concurrent use of alcohol and/or other central nervous system depressants, but to date there have been no studies to assess the effects of azelastine nasal spray on the CNS in humans. More recent studies<ref name="Corren et al, 2005">{{cite journal |vauthors=Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H |title=Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis |journal=Clinical Therapeutics |volume=27 |issue=5 |pages=543–53 |date=May 2005 |pmid=15978303 |doi=10.1016/j.clinthera.2005.04.012}}</ref><ref name="Berger et al, 2006">{{cite journal |vauthors=Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO |title=Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis |journal=Annals of Allergy, Asthma & Immunology |volume=97 |issue=3 |pages=375–81 |date=September 2006 |pmid=17042145 |doi=10.1016/S1081-1206(10)60804-6}}</ref> have shown similar degrees of somnolence (approx. 2%) compared with placebo treatment. The problem of bitter taste may be reduced by correct application of the nasal spray (i.e. slightly tipping the head forward and not inhaling the medication too deeply), or alternatively using the azelastine/sucralose formulation.

 

